Free shipping on all orders over $ 500

PCO371

Cat. No. M10540

All AbMole products are for research use only, cannot be used for human consumption.

PCO371 Structure
Synonym:

PCO-371

Size Price Availability Quantity
1mg USD 120  USD120 In stock
5mg USD 290  USD290 In stock
10mg USD 450  USD450 In stock
25mg USD 900  USD900 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PCO371 is a novel, orally active small molecule full agonist of PTHR1. PCO371 does not affect the PTH type 2 receptor (PTHR2). Oral administration of PCO371 to osteopenic rats provokes a significant increase in bone turnover with limited increase in bone mass. In hypocalcemic rats, PCO371 restores serum calcium levels without increasing urinary calcium, and with stronger and longer-lasting effects than PTH injections. PCO371 induces cAMP production with an EC50 of 2.4 μM in COS-7 cells expressing hPTHR1, and 2.5 μM in COS-7 cells transfected with hPTHR1-delNT, and also enhances the phospholipase C activity (EC50=17 μM).

Chemical Information
Molecular Weight 635.65
Formula C29H32F3N5O6S
CAS Number 1613373-33-3
Form Solid
Solubility (25°C) DMSO 95 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Yoshikazu Nishimura, et al. J Med Chem. Lead Optimization and Avoidance of Reactive Metabolite Leading to PCO371, a Potent, Selective, and Orally Available Human Parathyroid Hormone Receptor 1 (hPTHR1) Agonist

[2] Tatsuya Tamura, et al. Nat Commun. Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism

Related Thyroid Hormone Receptor Products
Thyroid hormone receptor antagonist (1-850)

Thyroid hormone receptor antagonist (1-850) is a competitive, selective and high-affinity thyroid hormone receptor (TR) antagonist with an IC50 of 1.5 μM for antagonizing the effect of T3 on TR. Thyroid hormone receptor antagonist (1-850) blocks T3-mediated interaction of TRα and TRβ with nuclear receptor coactivator.

CO23

CO23 is a selective thyroid hormone receptor (TR) α agonist, it is used for growth and development regulation. CO23 can be transported through the blood-brain barrier.

3,5-Diiodothyropropionic acid 

3,5-Diiodothyropropionic acid is a thyroid hormone analog, induces α-myosin heavy chain mRNA expression, binds to thyroid hormone receptor (TR), with Ka of 2.40 and 4.06 M-1 for TRα1 and TRβ1, respectively.

ZYT-1

ZYT-1 is a thyroid receptor (THR-β) agonist.

VK-0214

VK-0214 is an orally active, selective small molecule agonist of the thyroid receptor (THR-β) for studies related to X-linked adrenoleukodystrophy (X-ALD) and hyperlipidemia.

  Catalog
Abmole Inhibitor Catalog




Keywords: PCO371, PCO-371 supplier, Thyroid Hormone Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.